期刊文献+

甲型流感病毒分支状M2e多肽疫苗不同途径免疫效果的研究 被引量:1

Effects of branched M2e polypeptides influenza A vaccine immunized through different routes
原文传递
导出
摘要 目的 比较甲型流感病毒分支状多肽疫苗最佳免疫途径.方法 通过化学方法合成(M2e) 4-tuftsin,与Al(OH)3佐剂混合,肌注途径免疫小鼠;与JY佐剂混合,滴鼻免疫小鼠,观察两种途径的免疫效果.结果 肌内注射免疫途径诱导产生抗体的能力高于滴鼻免疫,(M2e) 4-tuftsin滴鼻免疫诱导细胞免疫的能力最强,(M2e)4-tuftsin通过肌肉注射和滴鼻免疫途径均对小鼠有一定的保护效果,但肌注免疫效果最好.结论 分支状M2e多肽肌内注射比滴鼻免疫保护效果好。 Objective To compare the immune effects induced with universal influenza A vaccine based on branched M2e polypeptides by two immunization routes in mice.Methods The M2e monomer and (M2e)4-tuftsin were synthesized using chemical method.One group of mice were immunized intramuscularly (i.m.) with 10 μg of (M2e)4-tuftsin plus aluminum adjuvant.And the other group of mice were intranasally immunized with the same amount of polypeptides plus JY adjuvant.Then the immune effects of different immune pathways were observed.Results Intramuscular route induced higher level of M2 specific antibody than intranasal route.Intramuscular injection of (M2e)4-tuftsin was the most effective in stimulating T cell responses.Both intramuscular and intranasal vaccinations (M2e) 4-tuftsin had protective effect,but intramuscular vaccination could provide the most efficient protective immunity.Conclusion The data indicated that the intramuscular vaccination could be the better way for immunization than intranasal vaccination.
出处 《中华实验和临床病毒学杂志》 CAS CSCD 2015年第3期199-202,共4页 Chinese Journal of Experimental and Clinical Virology
关键词 肽类 疫苗 DNA 佐剂 免疫 免疫 黏膜 免疫接种 加强 流感病毒A型 Peptides Vaccines, DNA Adjuvants, immanongic Immunity, mucosal Immunization, secondary Influenza A virus
  • 相关文献

参考文献11

  • 1Pica N, Palese P. Toward a Universal Influenza Virus Vaccine: Prospects and Challenges. Annual Review of Medicine, 2013, 64 : 189-202.
  • 2程小雯,郭元吉.流行性感冒病毒及其实验技术.北京:中国三峡出版社,1997:28.
  • 3Michael S, Marina DF, Walter F, et al. Universal M2 eetodomain-based influenza A vaccines: preclinieal and clinical developments. Expert Rev Vaccines,2009, 8 : 499-508.
  • 4徐萍,王小理,王玥,熊燕.应对流感大流行的疫苗新技术[J].生物产业技术,2010(2):38-42. 被引量:2
  • 5Tam JP. Synthetic peptide vaccine design: synthesis and properties of a high -density multiple antigenic peptide system. Proc Natl Acad Sci USA, 1988, 85:5409-5413.
  • 6Victor A. Tuftsin A Natural Activator of Phagocyte Cells: An Overview. Annals New York Academy of Sciences, 1983, 419: 1-1l.
  • 7Liu XY, Guo JQ, Hart S, et al. Enhanced immune response induced by a potential influenza A vaccine based on branched M2e polypeptides linked to tuftsin. Vaccine, 2012, 30: 6527-6533.
  • 8Mozdzanowska K, Zharikova D, Cudie M, et al. Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse. Viral J, 2007, 4: 118-131.
  • 9Zhao GY, Lin YP, Du LY, et al. An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses. Virul J, 2010, 7:9 - 17.
  • 10G6bor M, Adri6n K, Judit R, et al. Synthesis, conformation, and immunoreactivity of new carrier molecules based on repeated tuftsin-like sequence. Wiley Inter Science, 2004, 73: 645-656.

二级参考文献8

  • 1Ellebedy AH,Webby RJ.Influenza vaccines.2009,27(4):65-68.
  • 2Sambhara S,Styephenson I.Moving influenze vaccines forward .Expert Review of Vaccines,2009,8(4):375-377.
  • 3Monto A.S,Obmit S.E.Seasonal influenza vaccines:evolutions and future trends.Expert Review of Vaccines.Vaccines.2009,8(4):383-389.
  • 4Ellebedy AH,Webby RJ.Influenza vaccines,2009,27(sup4):D65-D68.
  • 5Jianhua Sui,William C Hwang,Sandra Perez,et al.Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses.Structural &Molecular Biology,2009,16:265-273.
  • 6European Mediciness Agency pandemic influenza preparedness .http://www.ema.europa.eu/htms/human/pandemicinfluenza/vaccines.htm.
  • 7Palache B,Krause R.Progress with human H5N1 vaccines:a perspective from industry.Expert Review of Vaccines.2009,8(4):391-400.
  • 8Yvonne Genzel,Udo Reichl.Continuous cell lines as a production system for influenza vaccines.Expert Review of Vaccines,2009,8(12):1681-1692.

共引文献2

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部